| 1. | soccerbooters | |
| 2. | joeholidaybuys | |
| 3. | djbenmacias | |
| 4. | candiskingdom | |
| 5. | bugbeas499315 |
Top Board Researchers
These are the top researchers based on quality of posts as voted by board members. Typically they know their stuff and are a great
way to catch up on what the company is all about.
HOW DO I BECOME ONE?
Just do great research! As other members approve of your posts, you earn points that move you up the ranks.| 1. | toonses85 02/14/2018 end at low of day, not good |
| 2. | joeholidaybuys 06/25/2018 Lexicon Pharmaceuticals Announces Positive 52-Week Results From Sotagliflozin inTandem1 Study Presented at ADA 2018 and Published in Diabetes Care |
| 3. | soccerbooters 05/04/2018 new XERMELO data from the Phase 3 TELESTAR study in Clinical Therapeutics |
| 4. | djbenmacias 03/29/2018 Lexicon Pharmaceuticals Announces EMA Acceptance of Marketing Authorization Application (MAA) for Sotagliflozin to Treat Adults With Type 1 Diabetes |
| 5. | candiskingdom 02/26/2018 Lexicon Pharmaceuticals Reports Fourth Quarter and Full-Year 2017 Financial Results and Provides a Business Update |
| 6. | soccerbooters 02/14/2018 8.09 now {Image} |
| 7. | candiskingdom 02/14/2018 Scared to hold to be honest |
| 8. | bugbeas499315 02/14/2018 JPMorgan cuts to underweight, $10PT |
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW
Lexicon Pharmaceuticals, Inc.
- LXRX
- Public Stock Message Board
Filtering by:
-
To use your chart in a post, click the
icon above the chart. From there you can get the chart link or download the image.